Chemotherapy-Induced Cardiomyopathy: Clinical Scenarios and Challenges
We will discuss the deleterious cardiovascular effects of anthracyclines and HER2-targeted agents in a case-based format, as well as specific approaches to prevention and treatment of associated cardiotoxicity.